We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreA dive into the complex and expensive world of gene therapy pricing and access.
Read moreOur experts predict the 5 trends they think will dominate the European pricing and market access lan...
Read moreCell and gene therapies - life saving opportunity for many patients
Read moreZolgensma launched in May 2019 in the US for $2.1 million, whilst Zynteglo was launched in the EU in...
Read moreThe development of gene therapies represents a new frontier of science, with the potential to help p...
Read more